The report states Oriana Power received a new Rs 375 crore contract for a 75 MW solar power plant from Maharashtra State Electricity Distribution Company under the PM-KUSUM Scheme.
Read this note →Research notes
What India's research desks published, reported with attribution and linked to the original notes. Orivam issues no recommendations of its own.
92 notes from Way2Wealth · all time
The report notes Bajaj Auto's consolidated net profit fell 31.4% to Rs 1,385.44 crore in Q2 FY25 due to a one-time deferred tax payment, while revenue grew 22.2% to Rs 13,247.28 crore and EBITDA rose 24% YoY to a record Rs 2,653 crore.
Read this note →The note says EPL delivered a robust Q4FY25 with revenue up 7.4% YoY to Rs 11,054mn, EBITDA margin expansion of 208bps to 20.6% and PAT up 666% YoY, and recommends a Hold rating given balanced growth potential and cost leadership offset by near-term macro uncertainties, with the stock trading at 18x FY27E EPS.
Read this note →The note lists an intraday idea to sell the IGL future below 180 with a target of 172 and a stoploss of 185.
Read this note →The note lists an intraday idea to buy above 484 with a target of 500 and a stoploss of 474.
Read this note →The note lists an intraday idea to buy above 4890 with a target of 5140 and a stoploss of 4880.
Read this note →The report says APL Apollo is fundamentally poised for growth with capacity rising toward a targeted 5mn tons, but at 33x FY25E and 29x FY26E P/E the stock is fully priced with limited upside, so it recommends a HOLD and adds that those looking to move to greener pastures can begin partial profit booking.
Read this note →The note says LTTS reported Q4FY24 revenue of US$305.1mn (+5.0% QoQ, +5.8% YoY) with EBIT margin at 16.9% and PAT of Rs 3.41bn, and that Way2Wealth maintains its ACCUMULATE stance citing strong fundamentals and clientele, with the stock trading at 31.7x FY26E EPS of Rs 148.2, while noting management has guided FY25 revenue growth of 8-10% and lowered margin guidance from 18% to 16%.
Read this note →The note says JK Cement delivered a 67% YoY rise in Q1FY25 profit to Rs 185crs on 5% volume growth and lower energy costs, is on track for 30mtpa capacity by FY26, and recommends accumulating on dips with the stock trading at 14x FY26E EV/EBITDA, while flagging input-cost inflation and a significant decline in cement pricing as key risks.
Read this note →The note says Gabriel India reported Q1FY25 revenue of ~Rs 9.5bn (+18% YoY) with EBITDA margin at 9.6% and PAT up 37.1% YoY, and retains a BUY with a target range of Rs 590-600 based on 19.3x FY26E EPS of Rs 25.3, citing Core-90 programme benefits, the sunroof business at ~14% EBITDA margin despite DPIIT rejecting the Inalfa JV, new products (solar dampers, e-bike suspension) and a debt-free balance sheet.
Read this note →The morning call tracker lists an open buy call on Kajaria Ceramics from 12-08-2026 with entry 1225.60, stop loss 1181 and target 1310.
Read this note →The morning call tracker lists an open buy call on BHEL from 13-08-2026 with entry 420, stop loss 401 and target 480.
Read this note →The morning call tracker lists an open buy call on Crisil from 31-08-2026 with entry 4732, stop loss 4520 and target 5025.
Read this note →The morning call tracker lists an open buy call on Fivestar from 15-09-2026 with entry 551, stop loss 515 and target 636.
Read this note →The report notes Kotak Bank was the only Bank Nifty constituent to close in the green.
Read this note →The report says Bank Nifty closed near 56,055.75 after reversing from its high, with support at 55,600 and resistance at 56,500, recommending a cautious-to-bearish stance and avoiding aggressive fresh longs.
Read this note →The report says Nifty gained 53 points to close at 23,270.60, faces resistance near 23,483 and 23,600, and advises using rallies towards 23,500-23,600 to reduce long exposure while maintaining a cautious stance.
Read this note →The report lists Glenmark Pharma as a stock to watch likely to show relative strength given Pharma's strong technical structure.
Read this note →The report lists Torrent Pharma as a stock to watch likely to show relative strength given Pharma's strong technical structure.
Read this note →The report lists Granules as a stock to watch likely to show relative strength given Pharma's strong technical structure.
Read this note →The report lists Lauras Lab as a stock to watch likely to show relative strength given Pharma's strong technical structure.
Read this note →The report recommends buying Five-Star Business Finance in the range of 540-551 with a stoploss of 515 and a target of 636 over 1-2 months.
Read this note →The report notes a closed Buy call on Prestige Estates from 17-08-2026 that resulted in a 4% loss.
Read this note →The report notes a closed Buy call on Ashok Leyland from 27-08-2026 that resulted in an 8% loss.
Read this note →The report notes a closed Buy call on MapmyIndia from 01-09-2026 that resulted in a 6% loss.
Read this note →